SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+6.94%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.32B
AUM Growth
+$1.32B
(-7%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$33.4M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$25.4M |
| 3 |
Alignment Healthcare
ALHC
|
$23.1M |
| 4 |
Vor Biopharma
VOR
|
$23.1M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$21.9M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$38.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$35M |
| 3 |
Labcorp
LH
|
$31.5M |
| 4 |
Exelixis
EXEL
|
$29.6M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Maravai LifeSciences
MRVI
$337M
| – | – |
-978,600
| Closed | -$27.5M |
|
127
Replimune Group
REPL
$457M
| – | – |
-667,729
| Closed | -$25.5M |
|
128
Revolution Medicines
RVMD
$7.41B
| – | – |
-389,006
| Closed | -$15.4M |
|
129
Seer Inc
SEER
$114M
| – | – |
-94,681
| Closed | -$5.32M |
|
130
Sarepta Therapeutics
SRPT
$2B
| – | – |
-86,624
| Closed | -$14.8M |
|
|
PSTX
131
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-838,826
| Closed | -$9.2M |
|
|
SILK
132
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-399,483
| Closed | -$25.2M |
|
|
DCPH
133
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-488,842
| Closed | -$27.9M |
|
|
AFIB
134
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| – | – |
-982,236
| Closed | -$28.3M |
|
|
SGTX
135
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| – | – |
-225,000
| Closed | -$10.8M |
|